Ethical Compliance
WINDLAS BIOTECH
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Market Cap Class:
small
Revenue
2%
Debt
0%
Liquidity
4.9%
Revenue
Debt
Liquidity
2%
Non Compliant
Questionable
Compliant
Compliant
INR Crores
| Pharmaceuticals | ₹599.39 |
| Export Sales | ₹27.39 |
| Sale of Services | ₹2.11 |
| Other Operating Income | ₹2.07 |
| Other Income | ₹0.68 |
Questionable
INR Crores
| Net Gain on Sale of Investments | ₹10.82 |
Non Compliant
INR Crores
| Interest income | ₹1.97 |
INR Crores
| Revenue from Questionable Sources: | ₹10.82 |
| Revenue from Non Compliant Sources: | ₹1.97 |
| Total: | ₹12.79 |
| Total Revenue: | ₹644.42 |
Formula
Revenue from Questionable & Non Compliant Sources
Total Revenue
≤ 0.03 or 3%
Calculation
₹12.79
₹644.42
= 2%
compliant
Rationale
The sum of revenue from questionable and non-compliant sources should not exceed 3% of the total revenue. This ensures that the company has tolerable reliance on unethical sources of revenue.
